Back to results
US 2026/0060971 A1Published application
Methods of treating solid tumors having activation fgfr3 gene alterations
AssigneeTyra Biosciences, Inc.
InventorsHiroomi TADA, Robert L. HUDKINS, Piyush PATEL, Daniel C. BENSEN, Timothy Campbell BURN
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods of treating cancers that have activating FGFR3 gene alterations by administering a compound of Formula (I) as disclosed herein, or a pharmaceutically acceptable salt of a compound of Formula (I).
Claims23
A method of treating cancer in a patient in need thereof, comprising administering to the patient a compound of Formula (I),
- or a pharmaceutically acceptable salt thereof.
-10. (canceled)
-27. (canceled)
-66. (canceled)
Dependencies are inferred from the claim text.